Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads

Abstract

The aim of the present study was to investigate the expression of toll-like receptors (TLR) 9 in peripheral blood mononuclear cells (PBMC) of patients with chronic hepatitis B and C with different virus copies. The study group included 90 patients (60 with chronic hepatitis B, and 30 with chronic hepatitis C), and 20 healthy people served as control group. The protein and mRNA levels of TLR9 were detected by using flow cytometry and real-time PCR. The serum viral copies of HBV and HCV were measured in all patients, and the correlation between HBV-DNA copies or HCV-RNA copies and the TLR9 expression was analyzed. Our results demonstrated that HBV or HCV infection led to a decreased expression of TLR9 mRNA and protein compared to the control group (P<0.05). The TLR9 protein and mRNA levels were negatively correlated with serum viral copies of HBV and HCV (r=−0.632, r=−0.909, P<0.01). It was concluded that TLR9 mRNA and protein are down-regulated in PBMC of HBV-infected or HCV-infected patients, and they are negatively correlated with serum viral copies and play an important role in detecting viral replication of HBV and HCV.

Keywords

peripheral blood mononuclear cells / innate immunity / toll-like receptor 9

References

[1] VisvanathanK., LewinS.R.. Immunopathogenesis: role of innate and adaptive immune responses. Semin Liver Dis, 2006, 26: 104-115

[2] ChisariF.V., FerrariC.. Hepatitis B virus immunopathogenesis. Annu Rev Immunol, 1995, 13: 29-60

[3] MoriishiK., MatsuuraY.. Mechanisms of hepatitis C virus infection. Antivir Chem Chemother, 2003, 14(6): 285-297

[4] CernyA., McHutchisonJ. G., PasquinelliC., et al. . Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Investig, 1995, 95: 521-530

[5] LechnerF., WongD. K., DunbarP. R., et al. . Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med, 2000, 191: 1499-1512

[6] ShoukryN. H., GrakouiA., HoughtonM., et al. . Memory CD8 T cells are required for protection from persistent hepatitis C virus infection. J Exp Med, 2003, 197: 1645-1655

[7] ThimmeR., OldachD., ChangK. M., et al. . Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med, 2001, 194: 1395-1406

[8] TakedaK., KaishoT., AkiraS.. Toll-like receptors. Ann Rev Immunol, 2003, 21: 335-337

[9] MedzhitovR., JanewayC.Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev, 2000, 173: 89-97

[10] WerlingD., JungiT.W.. Toll-like receptors linking innate and adaptive immune response. Vet Immunol Immunopathol, 2003, 91: 1-12

[11] TakedaK., AkiraS.. Toll-like receptors in innate immunity. Int Immunol, 2005, 17: 1-14

[12] JanewayC.A.Jr, MedzhitovR.. Innate immune recognition. Annu Rev Immunol, 2002, 20: 197-216

[13] IwasakiA., MedzhitovR.. Toll-like receptor control of the adaptive immune responses. Nat Immunol, 2004, 5: 987-995

[14] HornungV., RothenfusserS., BritschS., et al. . Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol, 2002, 168: 4531-4537

[15] SchlaepferE., AudigeA., JollerH., et al. . TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J Immunol, 2006, 176: 2888-2895

[16] ItoT., WangY.H., LiuY.J.. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9. Springer Semin Immunopathol, 2005, 26: 221-229

[17] YangK., PuelA., ZhangS., et al. . Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity, 2005, 23: 465-478

[18] KrugA., LukerG.D., BarchetW., et al. . Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood, 2004, 103: 1433-1437

[19] AndersenJ.M., Al-KhairyD., IngallsR.R.. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod, 2006, 74: 824-831

[20] HuangY.H., ChouM.H., DuY.Y., et al. . Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia. Lab Invest, 2006, 87: 66-74

[21] LesmeisterM.J., BothwellM.R., MisfeldtM.L.. Toll-like receptor expression in the human nasopharyngeal tonsil (adenoid) and palantine tonsils: a preliminary report. Int J Pediatr Otorhinolaryngol, 2006, 70: 987-992

[22] Chinese Society of HepatologyChinese Society of Infectious Diseases CMA.. The guideline of prevention and treatment for chronic hepatitis B. Chin J Hepatol (Chinese), 2005, 13: 881-890

[23] RossJ.W., AshworthM.D., HurstA.G., et al. . Analysis and characterization of differential gene expression during rapid trophoblastic elongation in the pig using suppression subtractive hybridization. Reprod Biol Endocrinol, 2003, 1: 23

[24] ChuangT.H., UlevitchR.J.. Cloning and characterization of a subfamily of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw, 2000, 11: 372-378

[25] DuX., PoltorakA., WeiY., et al. . Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw, 2000, 11: 362-371

[26] IsogawaM., RobekM.D., FuruichiY., et al. . Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol, 2005, 79: 7269-7272

[27] AnH., XuH., YuY., et al. . Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kappaB, ERK and p38 MAPK signal pathways. Immunol Lett, 2002, 81: 165-169

[28] McKimmieC.S., JohnsonN., FooksA.R., et al. . Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem Biophys Res Commun, 2005, 336: 925-933

[29] BauerS.. Toll-erating self DNA. Nat Immunol, 2006, 7: 13-15

[30] BartonG.M., KaganJ.C., MedzhitovR.. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol, 2006, 7: 49-56

[31] SchmausserB., AndrulisM., EndrichS., et al. . Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol, 2004, 136: 521-526

[32] LeeJ., RachmilewitzD., RazE.. Homeostatic effects of TLR9 signaling in experimental colitis. Ann N Y Acad Sci, 2006, 1072: 351-355

[33] Eaton-BassiriA., DillonS.B., CunninghamM., et al. . Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect Immun, 2004, 72: 7202-7211